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Summary: Zinc concentrations and Cu, Zn Superoxide dismutase activity in erythrocytes were investigated in
138 healthy children and in 35 children with cancer. The mean zinc concentration in the erythrocytes of
healthy children was found to be age-dependent. In the youngest group (children up to l year of age) the
zinc concentration in erythrocytes is 18.8 + 3.4 μg/g Hb (5.89 + 1.23 mg/1 packed cells), which is significantly
lower than in other age groups. A strong logarithmic correlation (r = 0.327, p < 0.0001 and r = 0.436,
p < 0.00001) was found between age and zinc concentration in erythrocytes, expressed s μg/g Hb and s
mg/1 packed red cells, respectively.
Cancer children were divided into two groups (neuro- and nephroblastoma). In the group of children with
neuroblastoma no statistical differences in zinc concentration or enzyme activity were observed. In the patients
with nephroblastoma, significantly higher zinc concentrations (p < 0.05) were observed in erythrocytes. The
changes of zinc concentration re accompanied by significant (p < 0.02) decreases of enzyme activity. In this
group of cancer children, statistic lly significant differences were observed in the zinc concentrations in
erythrocytes (μ$/§ Hb) between the second and the third stages of the disease. No correlation was observed
between the concentration of zinc and enzyme activity in healthy children or in cancer children.
Introduction in males, poor appetite, mental lethargy and skin
Λ , . - , , - . changes. These Symptoms were abolished by zinc sup-Over the years, the importance of the role of zinc m ; . //1ΛΛ ι. · ι / - j - j LI plementation (4).the human orgamsm has received considerable atten-
tion. In 1961, Prasad et al. (1), indicated for the first Most of the zinc in human blood (75-88%) is found
time that zinc deficiency may occur in humans. Clin- in the erythrocytes, where its concentration seems to
ical manifestations of zinc deficiency were described be less variable than in plasma or serum (5). Zinc has
in the early sixties in subjects from the Middle Hast been implicated in a large number of biological func-
(2, 3); these were growth retardation, hypogonadism tions, most of them involving this element s an
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essential component of metalloenzymes (4). More
than 200 zinc-containing enzymes are known to par-
ticipate in many metabolic processes including nucleic
acid, lipid and protein synthesis or degradation. The
metal is present in several dehydrogenases, aldolases,
peptidases, and phosphatases (4).
Ohno et al. (6), demonstrated that 92.4% of the total
zinc content of erythrocytes is present in carbonic
anhydrase (87%) and Zn, Cu containing Superoxide
dismutase (5.4%).
Copper and zinc-containing Superoxide dismutase
(EC 1.15.1.1) catalyses the dismutation of Superoxide
anions to hydrogen peroxide, thus protecting the cell
against Superoxide radicals. In recent years, many
publications have appeared on the subject of super-
oxide dismutase in malignant disease. However, the
conclusions drawn have in general been based on few
experimental observations, and those mainly on ani-
mal tumours (7, 8, 9). Little is known about Cu, Zn
Superoxide dismutase activity in the erythrocytes of
cancer patients, and in cancer children in particular.
Because abnormalities in zinc levels have been ob-
served in association with certain malignancies (l -
4), we decided to make a comprehensive study of
the zinc concentration and Superoxide dismutase ac-




Zinc concentrations in erythrocytes were assayed in 138 healthy
children aged 2 months—16 years (56 girls and 82 boys) from
different parts of Poland, mainly from the central region. Su-
peroxide dismutase activity in blood cells was determined in
112 children (46 girls and 66 boys). Venous blood samples for
the investigation were taken from the cubital vein and placed
in heparinized test tubes free from trace elements. The hae-
matocrit and haemoglobin concentration (using Drabkin's TQ-
agent) were determined in the whole blood. The remaining
blood was centrifuged for 5 min at 5000 min~1 to remove
plasma and buffy coat. Erythrocytes were washed 3 times with
9 g/l NaCl, then diluted with isotonic sodium Chloride. The
haematocrit and haemoglobin were determined in the resulting
erythrocyte Suspension, which was then stored at —20 °C until
zinc analysis.
Cancer children
Zinc concentration and Superoxide dismutase activity were de-
termined in two groups of cancer children.
The first group consisted of 18 children (9 girls and 9 boys)
with recognized neuroblastoma.
The second group included 17 children (5 girls and 12 boys)
aged l — 6 years, with nephroblastoma (tumour Wümsi).
In the first group, 5 children (2 girls and 3 boys) were investi-
gated at the time of diagnosis, while a further 13 children had
already previously received chemo- and radiotherapy.
Five children with nephroblastoma (l girl and 4 boys) were
examined before their treatment began and 12 children (4 girls
and 8 boys) were examined in the course of treatment with
cytostatic pharmaceuticals or/and radiotherapy. The methods
of drawing, preparation, and storage of samples for investiga-
tion were the same äs for healthy chüdren.
Zinc determination , f
The zinc concentration in the red blood cells of healthy äs well
äs cancer children was determined by the inethod of Agarwat
et al. (15), using a Beckman Model 1248 atomic absorption
spectrophotometer with a deuterium background cprrectpr.
Zinc concentrations in erythrocytes were expressed äs g/g Hb
and mg/1 packed cells.
Lyophilized Standard blood samples of the International
Atomic Energy Agency (A-13) were used to monitor the äccil·-
racy of zinc analysis. The mean zinc content in these samples,
calculated from ten successive series of determination, was 12.5
± 0.97 ^/g dry weight. The reference zinc value for the Stand-
ard was stated to be 13.0 g/g dry weight with 95% confidence
interval (16). The coefficient of Variation was less than 10%
for red blood cells (n = 8).
Enzyme preparation and assay
The red blood cell lysate was prepäred äs described by Minami
& Yoshikawa (17).
Haemoglobin was precipitated by vigprous shaking with chlo-·
roform : ethanol (l 4- 2, by vol.) (18). After centrifugation, the
clear supernatant was used for Superoxide dismutase determi-
nation. Enzyme activity was measured by the spectrophoto-
metric method (Pye Unicam SP-500 series 2 spectrophotometer)
according to Misra & Fridovich (19). The assay is based on the
Inhibition by Superoxide dismutase of the Superoxide radical-
mediated conversion of adrenaline to ädrenochrome in
pH = 10.2 medium. The enzyme activity was calculated äs
arbitrary units per mg of haemoglobin,
The data obtained were used to calculate means, Standard
deviations, and correlation coefficient. Statistical significance




The results obtained in healthy children are presented
in table 1. The mean zinc concentration in erythro-
cytes of healthy children increased with the age of the
child. In the group of children up to l year of age the
concentration of zinc in erythrocytes was 18.8 ± 3.4
g/g Hb (5.89 ± 1.23 mg/1 packed cells), which was
significantly lower than in other age groups. From
the 4th to the 7th year of age the concentration of
zinc in erythrocytes was 34.9 ± 6.7 g/g Hb (11.49
± 2.52 mg/1 packed cells) (p < 0.001 äs compared
with the youngest children). The erythrocyte zinc con-
centration of older children showed no further ehange,
attaining a value of 33.4 ± 8.24 g/g Hb at 8-16
years of age.
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Zinc concentration and Superoxide dismutase activity





12 3.51 ± 0.34*
31 3.60 ± 0.52
n = 27
NS
33 3.29 ± 0.52
n = 13
NS



































-related differences in erythrocyte zinc concen-
and Superoxide dismutase activity were found.
•
:
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Age [a]
Relationship between age and zinc concentration in
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* Mean ± Standard deviation;
** Statistical significance was calculated in comparison with
the youngest children.
NS Non-significant.
A positive statistically highly significant logarithmic
correlation (r = 0.436, p < 0.00001, and r = 0.327,
p < 0.0001, fig. 1) was found between age and zinc
concentration in erythrocytes, expressed s mg/1
packed erythrocytes, s μg/g Hb, respectively.
Superoxide dismutase activity in children aged up to
l year was 3.51 ± 0.34 U/mg Hb and this value
remained unchanged up to the 16th year of age (tab.
1). No significant correlation was found between Su-
peroxide dismutase activity and zinc concentration in
erythrocytes.
y = 26.41 + 3.26 In χ
r = 0.327; p < 0.0001
Cancer children
The results obtained in cancer children are presented
in tables 2 and 3. In the group of children with
neuroblastoma no Statistical differences in zinc con-
centration or the enzyme activity were observed s
compared with the age-matched group of healthy
children (tab. 2). No significant differences in the
concentration of zinc and Superoxide dismutase activ-
ity at different stages of the disease were observed
(tab. 3). Differences in erythrocyte enzyme activity
and zinc concentration between untreated children
and children under treatment before the examination
were not statistically significant.
Tab. 2 Zinc concentration and Cu, Zn Superoxide dismutase activity in erythrocytes and basic haematological parameters of
cancer children.


































































* Number of subjects
** Significant difference in comparison with age-matched group of healthy children
NS Non-significant
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Tab. 3. Malignant stage and zinc concentration and Cu, Zn Superoxide dismutase activity in erythrocytes of cancer children.












































































* Number of subjects
** Statistically significant difference in comparison with IInd stage of disease
NS non-significant
In the patients with tumour Wilmsi the measured
concentration of zinc in erythrocytes was significantly
higher than in the healthy age-matched group (tab.
2). The difference amounted to 16.3% (p < 0.005)
^g/g Hb), and 19.1% (mg/1 packed erythrocytes).
The changes of zinc concentration are accompanied
by significantly lowered Superoxide dismutase activity
(l3.6%; p < 0.02) (tab. 2).
In the children with tumour Wilmsi a Statistically
significant difference (p < 0.05) was observed in the
zinc concentration in erythrocytes fag/g Hb) between
the second and the third stages of the disease (tab.
3). No significant differences in the concentration of
zinc or the activity of the enzyme were observed
between treated and untreated nephroblastoma pa-
tients.
Discussion
The zinc concentration in human red blood cells is
approximately 14 times higher than in plasma (20).
Measurements of zinc in erythrocytes may therefore
be useful äs an indication of long-term zinc Status,
since these cells have an average life-span of 120 days.
The data of Hihks et äl. (21) demöiistrate that ap-
proximately 90% of the blood zinc is associated with
the erythrocytes, while the plasma contains 9% of the
total blood zinc. Linderman et al. (22) determined the
zinc concentration in erythrocytes of men and women
aged 20—89 years, and found a positive linear cor-
relation between age and zinc concentration. Other
authors confirm the linear correlation between the
age of the examined subjects and zinc concentration
both in plasma (23) and in whole blood (5).
Contrary to the work quoted above, our results in-
dicäte a logarithmic correlation between the age of
the examined children and the concentration of zinc
in erythrocytes. In our opinion, a logarithmic curve
describes more accurätely the differences in zinc con<-
centration in the erythrocytes of ehildren up to the
third year of age, äs well äs the plateau observed at
about 5-7 years (tab. l, fig. 1). In agreement with
Linderman et äl. (22), we found nö Statistically sigr
nificant sex differences in the mean erythrocyte zinc
concentrations. Our investigation did not reveal äny
age-dependent changes in the erythrocyte Superoxide
dismutase activity öf healthy children (tab. 1). Öther
authors (24—26) have reported similar cönclusiöns.
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Special interest has been focused on the role of zinc
in patients with malignant diseases (11, 23, 27 — 29).
Few reports, however, deal with changes in the con-
centration of zinc in erythrocytes, while none of the
available literature is addressed to the determination
of zinc in the erythrocytes of children with neoplastic
disease.
In the present investigation, statistically significant
increases in the zinc concentration of erythrocytes
were accompanied by simultaneous decreases in su-
peroxide dismutase activity in children with nephro-
blastoma. A similar but non-significant tendency was
observed in the group of children with neuroblastoma.
In the latter group the increase of zinc in erythrocytes
amounted to 9% (14.3% per packed erythrocytes),
whereas the enzyme activity was lowered by 9% (tab.
2). In plasma, zinc concentrations are usually low in
cancer patients (11, 23, 27, 29). Some investigators
associate the lowered concentration of the element in
plasma with an increased demand of the neoplastic
tissue for zinc (30). Aldor et al. (10) demonstrated a
decrease of zinc concentration in plasma, whole blood
and erythrocytes in patients with different forms of
neoplastic disease. The decrease was significant in
plasma and whole blood and non-significant in eryth-
rocytes.
The increased concentration of zinc in the erythro-
cytes of the examined children is difficult to Interpret.
It is possibly due to ineffective erythropoiesis, in that
the erythrocyte precursor normoblasts do not divide
and mature normally. A similarly high erythrocyte
zinc concentration is present in other clinical condi-
tions associated with ineffective erythropoiesis (31).
The reports on Superoxide dismutase activity in neo-
plastic disease are not cömprehensive and, äs already
mentioned, based upon examinatipn of neoplastic tis-
süe in aiiimals. So far, there have been few reports
on Superoxide dismutase activity in human erythro-
cytes and in normal and pathological human cell lines.
Saito et al. (32) demonstrated that Superoxide dis-
mutase activity in the erythrocytes of stomach cancer
patients was not significantly different from that of
normal subjects. Morepver, Marklundtl al. (33) found
no essential differences in the activity of the enzyme
between normal and neoplastic cell lines. In our in-
vestigation, the observed activity of the erythrocyte
enzyme was lowered by 9% in the case of neuroblas-
toma and by 13.7% in the case of nephroblastoma.
Since a molecule of Superoxide dismutase contains
atoms of two metals, copper and zinc (34), the activity
of the enzyme should depend on their concentration.
However, Vilas et al. (35) did not find a relation
between the concentrations of copper and zinc and
Superoxide dismutase activity, either in umbilical cord
blood or in the blood of neonates. In the blood of
rats, on the other hand, a lowered Superoxide dis-
mutase activity was observed äs a result of copper
deficiency (36). Copper is a part of the catalytic site
of Superoxide dismutase, so its deficiency may influ-
ence the activity of the enzyme, while zinc is a struc-
tural element of enzymatic protein and in extreme
cases can be replaced by other cations (37). Hence,
even considerable fluctuations in the concentration of
zinc in the tissues may not cause changes in Superoxide
dismutase activity.
In our opinion, not only the changes of zinc concen-
tration in the blood of children with neoplastic dis-
ease, but also the concentration of copper should be
taken into consideration. In addition, the ratio of
copper to zinc, regarded äs a specific marker of neo-
plastic disease (11, 23, 27, 28), should be calculated.
The concentration of other elements, antagonistic to
zinc should also be measured, e. g. the concentration
of selenium whose role in neoplastic processes has
recently been widely discussed (38). Examination of
the activity of not only Superoxide dismutase, but also
of catalase and glutathione peroxidase may provide
answers to many questions related to this problem.
Such investigations are now in progress.
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